Andrew J. Schwab, 10% Owner at Enliven Therapeutics, Inc. (ELVN), sold 440,000 shares at $16.00 ($7.0M) on 2023-08-24, disclosed to the SEC on 2023-08-28.
Open-market sale of $7.0M ELVN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.00 | 72,876 | $1.2M | 16.6% |
| 2 | $16.00 | 367,124 | $5.9M | 83.4% |
| Total | $16.00 avg | 440,000 | $7.0M | 100% |
| Filing → |
| CAMP | SELL | 2026-08-31 | $1.6M | — | Filing → |
| CAMP | SELL | 2026-08-26 | $45 | — | Filing → |
| CAMP | SELL | 2026-08-21 | $880K | — | Filing → |